Intrinsic Value of S&P & Nasdaq Contact Us

Embecta Corp. EMBC NASDAQ

NASDAQ Global Select • Healthcare • Drug Manufacturers - Specialty & Generic • US • USD

SharesGrow Score
61/100
3/7 Pass
SharesGrow Intrinsic Value
$30.67
+224.2%
Analyst Price Target
$22.50
+137.8%

Embecta Corp. (EMBC) has a consensus analyst rating of Sell, based on 4 analysts covering the stock. Of those, 1 recommend buying, 1 recommend holding, and 2 recommend selling.

The analyst consensus price target for EMBC is $22.50, representing a +137.8% upside from the current price of $9.46. Price targets range from a low of $20.00 to a high of $25.00.

Analyst Consensus — EMBC

Sell
Strong Buy
0
Buy
1
Hold
1
Sell
2
Strong Sell
0
4 analysts
Price Targets
Consensus$22.50
High$25.00
Low$20.00
Median$22.50
Last Month Avg-
Last Quarter Avg-
Last Year Avg$25.00
All-Time Count5
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message